Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada)

Cancer Causes and Control

Volumn 11, Issue 6, 2000, Pages 547-553

  Infante Rivard, Claire ^a,b   Krajinovic, Maja ^b   Labuda, Damian ^b,c   Sinnett, Daniel ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Childhood leukemia; Developmental toxicity; Gene polymorphisms; Parental smoking

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANADA; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENT; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SMOKING;

ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A1; FATHERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUEBEC; QUESTIONNAIRES; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 0034087099     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008976116512     Document Type: Article

References (35)

1. California Environmental Protection Agency (1997) Office of Environmental Health Hazard Assessment. Health Effects of Exposure to Environmental Tobacco Smoke. Final Report, September.
2. Trédaniel J, Boffetta P, Little J, Saracci R, Hirsch A (1994) Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinat Epidemiol 8: 233-255.
3. Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD, Robison LL (1999) Parental cigarette smoking and the risk of acute leukemia in children. Cancer 85: 1380-1388.
4. Hirnoven A (1999) Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 107(Suppl. 1): 37-47.
5. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65.
6. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaume PH, Guengerich FP (1992) Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol Pharmacol 41: 856-864.
7. Guengerich FP, Shimada T (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400: 201-213.
8. US Department of Health and Human Services (1998) The Eighth Report on Carcinogens, Public Health Service, National Toxicology Program.
9. Juchau MR, Boutelet-Bochan H, Huang Y (1998) Cytochrome-P450-dependent biotransformation of xenobiotics in human and rodent embryonic tissues. Drug Metab Rev 30: 541-568.
10. Hakkola J, Pelkonen O, Pasanen M, Raunio H (1998) Xenobiotic-metabolizing cytochrome P450 enzymes in the human fetoplacental unit: role in intrauterine toxicity. Crit Rev Toxicol 28: 35-72.
11. Whyatt RM, Bell DA, Jedrychowski W, et al. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19: 1389-1392.
12. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D (1999) Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93: 1496-1501.
13. Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D (1999) Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 10: 481-487.
14. Piegorsch WW, Weinberg CR, Taylor JA (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13: 153-162.
15. Begg CB, Zhang ZF (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3: 173-175.
16. Khoury MJ, Flanders WD (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 144: 207-213.
17. Baccichet A, Qualman SK, Sinnett D (1997) Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res 21: 817-823.
18. Cascorbi I, Brockmuller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56: 4965-4969.
19. Sorahan T, Lancashire RJ, Hultén MA, Stewart AM (1997) Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer 75: 134-138.
20. Ji BT, Shu XO, Linet MS, et al. (1997) Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst 89: 251-256.
21. Aubin J, Caouette L (1998) L'usage de la cigarette au Québec de 1985 à 1994: une comparaison avec le Canada. Can J Public Health 89: 22-27.
22. Santé-Canada (1999) Le tabagisme au Canada durant les 16 dernières années. Promotion de la santé en direct.
23. Infante-Rivard C, Jacques L (2000) An empirical study of parental recall bias. Am J Epidemiol (In press).
24. Dellacro VL, Kimmel CA (1997) Risk assessment of environmental agents for developmental toxicity: current and emerging approaches. Mutat Res 396: 205-218.
25. Crofts F, Taioli E, Trachman J, et al. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15: 2961-2963.
26. Landi MT, Bertazzi PA, Shields PG, et al. (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4: 242-246.
27. Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminski LS (1996) Characterization of purified human recombinant cytochrome P450 1A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res 56: 3926-3933.
28. Rumsby PC, Yardley-Jones A, Anderson D, Phillimore HE, Davies MJ (1996) Detection of CYP1A1 mRNA levels and CYP1A1 Msp 1 polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers. Teratog Carcinog Mutagen 16: 65-74.
29. Watanabe M (1998) Polymorphic CYP genes and disease predisposition - what have the studies shown so far? Toxicol Lett 102-103: 167-171.
30. d'Errico A, Malats N, Vineis P, Boffetta P (1999) Review of studies of selected metabolic polymorphisms and cancer. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, eds. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC Scientific Publications No. 148, pp. 323-393.
31. Gotoh O, Tagashira Y, lizuka T, Fujii-Kuriyama Y (1983) Structural characteristics of cytochrome P-450. Possible location of the heme-binding cysteine in determined amino-acid sequences. J Biochem (Tokyo) 93: 807-817.
32. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87.
33. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Pari FF (1998) Breast cancer and CYP1A1, GSTM1, GSTT1, polymorphism: evidence of a lack of association in Caucasian and African Americans. Cancer Res 58: 65-70.
34. Esteller M, Garcia A, Martinez-Palones JP, Xercavins J, Reventos J (1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18: 2307-2311.
35. Bolande RP (1999) Prenatal exposures and childhood cancer. Pediatr Dev Pathol 2: 208-214.